Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$0.61 and traded as low as C$0.59. Crescita Therapeutics shares last traded at C$0.59, with a volume of 9,974 shares.
Crescita Therapeutics Trading Down 1.7 %
The business has a 50 day moving average of C$0.61 and a 200 day moving average of C$0.50. The firm has a market capitalization of C$11.43 million, a price-to-earnings ratio of -3.93 and a beta of 1.71. The company has a debt-to-equity ratio of 6.02, a current ratio of 3.37 and a quick ratio of 2.29.
About Crescita Therapeutics
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Read More
- Five stocks we like better than Crescita Therapeutics
- The 3 Best Fintech Stocks to Buy Now
- How Much Can You Make in Stocks in One Month?
- What is a Secondary Public Offering? What Investors Need to Know
- This Is the Top Large-Cap Stock Insiders Are Buying
- Most active stocks: Dollar volume vs share volume
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
